Healthy Inc > Blog > Macrolide antibiotic exporter
Posted on:

What is Roxithromycin 150 mg used for?

In the pharmaceutical industry, Roxithromycin 150 mg is a semi-synthetic Macrolide antibiotic. As a pharmacist and manufacturer, I classify this as a “Second-Generation Macrolide.” It was developed to overcome the limitations of Erythromycin, offering better acid stability, a longer half-life, and significantly fewer gastrointestinal side effects.

Primary Clinical Uses

  • Respiratory Tract Infections (RTIs): Highly effective for both upper and lower RTIs, including acute pharyngitis, tonsillitis, sinusitis, and community-acquired pneumonia.

  • Skin and Soft Tissue Infections: Used for treating boils, carbuncles, folliculitis, and impetigo.

  • Urogenital Infections: Effective against certain non-gonococcal urethritis, particularly those caused by Chlamydia and Mycoplasma.

  • Odontogenic Infections: Frequently prescribed for dental abscesses and gum infections.

  • ENT Infections: A staple for Otitis Media (middle ear infections) in patients allergic to Penicillins.

Mechanism of Action: Inhibition of Protein Synthesis

Roxithromycin is primarily bacteriostatic, meaning it prevents bacteria from growing rather than killing them outright (though it can be bactericidal at high concentrations).

Ribosomal Binding: The drug binds reversibly to the 50S subunit of the bacterial ribosome.

Translocation Blockade: It specifically blocks the translocation step, where the growing peptide chain moves along the ribosome.

Protein Synthesis Inhibition: By stopping the assembly of essential proteins, the bacteria can no longer replicate or maintain their cellular functions.

High Tissue Concentration: Unlike many other antibiotics, Roxithromycin achieves very high concentrations inside macrophages and neutrophils, which then carry the drug directly to the site of infection (the “Trojan Horse” effect).

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your WHO-GMP facility in Mumbai, Roxithromycin 150 mg is a strategic product:

  • Acid Stability: Unlike Erythromycin, Roxithromycin is stable in gastric acid. This means we do not necessarily need expensive enteric coating, allowing for a more cost-effective film-coated tablet that still maintains high bioavailability.

  • The 150 mg Dosage: This is the standard adult dose, typically taken twice daily. For your digital platform, highlighting the BID (twice a day) dosing compared to the QID (four times a day) dosing of older macrolides is a major USP for patient compliance.

  • Stability & Packaging: Roxithromycin is stable but should be protected from extreme heat. We utilize Alu-Alu or high-grade PVC/PVDC blisters to ensure a 36-month shelf life for export to Zone IVb regions.

  • Dossier Support: This molecule is widely used in Southeast Asia, the Middle East, and Africa. Our Mumbai facility provides full CTD/eCTD Dossiers to support your international registration and trading efforts.

Roxithromycin Tablets

Posted on:

What is Clarithromycin 500mg used for?

In the pharmaceutical industry, Clarithromycin 500 mg is a semi-synthetic macrolide antibiotic derived from Erythromycin. As a pharmacist, I view Clarithromycin as a superior choice over older macrolides due to its improved acid stability, better tissue penetration, and its active metabolite (14-hydroxyclarithromycin) which provides synergistic antimicrobial activity.

Primary Clinical Uses

  • Helicobacter pylori Eradication: A critical component of “Triple Therapy” (usually combined with Amoxicillin and a Proton Pump Inhibitor like Omeprazole) to treat peptic ulcers and prevent recurrence.

  • Lower Respiratory Tract Infections: Highly effective for community-acquired pneumonia (CAP), acute exacerbations of chronic bronchitis, and “atypical” pneumonias caused by Legionella or Mycoplasma.

  • Upper Respiratory Tract Infections: Used for acute maxillary sinusitis, tonsillitis, and pharyngitis, especially in patients allergic to Penicillins.

  • Skin and Soft Tissue Infections: Treatment of uncomplicated infections like cellulitis, folliculitis, and erysipelas.

  • MAC Prophylaxis: Used to prevent or treat disseminated Mycobacterium avium complex (MAC) infections in immunocompromised patients (e.g., those with HIV/AIDS).

Mechanism of Action

Clarithromycin is primarily bacteriostatic. It works by penetrating the bacterial cell wall and binding to the 50S ribosomal subunit.

By binding at this specific site, it inhibits translocation, the process where the growing peptide chain moves along the ribosome. This halts bacterial protein synthesis, effectively preventing the bacteria from growing and multiplying, allowing the host’s immune system to clear the infection.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Clarithromycin 500 mg is a high-value antibiotic requiring specialized expertise:

  • Overcoming Bitterness: The Clarithromycin API is notoriously bitter. As a WHO-GMP manufacturer, we utilize advanced film-coating technology or specialized taste-masking polymers to ensure the 500 mg tablet is palatable for patients.

  • Acid Stability: Unlike Erythromycin, Clarithromycin is stable in gastric acid. However, we still optimize our formulation to ensure consistent dissolution and bioavailability, aiming for bioequivalence with the innovator (Biaxin/Klacid).

  • Stability for Global Trade: Clarithromycin is sensitive to moisture. We prioritize Alu-Alu blister packaging to guarantee a 24–36 month shelf life, particularly for export to Zone IVb climates (Africa, Southeast Asia, and the Middle East).

  • B2B & Registration: Our Mumbai-based hub provides comprehensive CTD/eCTD Dossiers and stability data to support our international partners in registering this essential antibiotic.

Clarithromycin Tablets

Add to cart